CVS Health Corp(CVS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:19 PM ET (Korea 10/27 05:19)
Full metrics table
| Index | S&P 500 | P/E | 24.43 | EPS (ttm) | 3.79 | Insider Own | 0.1% | Shs Outstand | 1.28B | Perf Week | -0.16% |
| Market Cap | 118.34B | Forward P/E | 10.86 | EPS next Y | 5.86% | Insider Trans | -72.91% | Shs Float | 1.28B | Perf Month | 3.81% |
| Enterprise Value | 180.89B | PEG | 0.84 | EPS next Q | 1.66 | Inst Own | 91.73% | Short Float | 1.29% | Perf Quarter | -15.37% |
| Income | 4.89B | P/S | 0.29 | EPS this Y | 19.24% | Inst Trans | 1.05% | Short Ratio | 2.06 | Perf Half Y | 18.08% |
| Sales | 415.11B | P/B | 1.48 | EPS next 5Y | 12.86% | ROA | 1.91% | Short Interest | 16.47M | Perf YTD | 16.6% |
| Book/sh | 62.36 | P/C | 8.48 | EPS past 3/5Y | -24.7% -23.94% | ROE | 6.23% | 52W High | -16.4% ($110.68) | Perf Year | 12.94% |
| Cash/sh | 10.91 | P/FCF | 10.06 | Sales past 3/5Y | 7.6% 8.4% | ROIC | 3.21% | 52W Low | 33.12% ($69.51) | Perf 3Y | 36.11% |
| Dividend Est. | $2.73 (2.95%) | EV/EBITDA | 9.41 | EPS Y/Y TTM | 6.51% | Gross Margin | 14.16% | Volatility(W/M) | 1.9% 2.42% | Perf 5Y | 4.77% |
| Dividend TTM | 2.66 | EV/Sales | 0.44 | Sales Y/Y TTM | 7.41% | Oper. Margin | 3.54% | ATR (14) | 2.2 | Perf 10Y | 5.66% |
| Dividend Ex-Date | 2026/10/22 | Quick Ratio | 0.66 | EPS Q/Q | 187.93% | Profit Margin | 1.18% | RSI (14) | 54.58 | Recom | 1.47 |
| Dividend Gr. 3/5Y | 5.74% 5.87% | Current Ratio | 0.87 | Sales Q/Q | 7.24% | SMA20 | 3.28% ($89.59) | Beta | 0.58 | Target Price | $113.88 |
| Payout | 191.23% | Debt/Eq | 0.96 | Earnings | 2026/11/4 | SMA50 | 1.11% ($91.51) | Rel Volume | 0.53 | Prev Close | $93.47 |
| Employees | 300000 | LT Debt/Eq | 0.91 | EPS/Sales Surpr. | 39.14% 6.07% | SMA200 | 4.46% ($88.58) | Avg Volume(3M) | 7.98M | Price | $92.53 |
| IPO | 1952/10/1 | Option/Short | Yes/Yes | Trades | 38021 | Volume | 4,254,524 | Change | -1.01% |
💊 An integrated healthcare company with a nationwide network of pharmacies and health clinics across the U.S., also operating prescription drug benefits management and health insurance (Aetna). Headquartered in Woonsocket, Rhode Island, its core strength lies in a vertically integrated model that combines pharmacies, drug pricing management, insurance, and primary care.
Over the past 1 year, roughly in the middle
16% below its 1-year high.
Traded less than usual. That is 53% of its average volume.
Next earnings report: November 4
9 days to go.
CVS has weak earnings and a weak balance sheet
Of every $100 in sales, $3.54 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +19.2% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company expected to earn $100 next year, you would pay $1,086. Peers typically go for $1,761. Compared with its own 5-year average, it is 39% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are roughly flat
Bought 5 years ago, your return today would be +4.8%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are more than it earns
It pays out 191% of what it earns.
Tap to view numbers
Ownership looks stable
Institutions hold 91.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #2 of 11 in the industry
Based on market cap of $118B.
UNH#1 Unitedhealth Group Inc $369B PER 23.4 
CVS#2 CVS Health Corp $118B PER 24.4 
ELV#3 Elevance Health Inc $93B PER 18.4 
CI#4 Cigna Group $81B PER 12.7 
HUM#5 Humana Inc $50B PER 39.5 
Earnings Analysis · 8/5 CVS Health ($CVS) Q2 2026 Earnings Analysis — Adjusted EPS Significantly Beats, Full-Year Guidance Raised Investing Guides · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats Investing Guides · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is CVS?
CVS belongs to the Healthcare sector and operates in the Healthcare Plans industry.
What is the market cap of CVS?
The market cap of CVS is approximately $118.3B, ranking 134 within its sector.
Does CVS pay dividends?
CVS has a dividend yield of approximately 2.95%, with an annual dividend of $2.73.
What is the P/E ratio of CVS?
CVS has a P/E ratio of approximately 24.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for CVS?
CVS has recorded a 52-week high of $110.68 and a low of $69.51.
